ganirelix
PolandDrugs containing this active substance
-
The medicine is used in women participating in assisted reproduction programs (e.g., in vitro fertilization) to prevent premature ovulation by inhibiting the rise in luteinizing hormone (LH) levels.
Form: solution for injection in ampoule-syringe
Active substance Dosage ganirelix 0,25 mg/0,5 ml ATC: H01CC01
Manufacturer: Sun Pharmaceutical Industries Europe B.V.
-
The medicinal product is used in women participating in assisted reproduction programs (e.g., in vitro fertilization) to prevent premature release of eggs (ovulation).
Form: solution for injection in ampoule-syringe
Active substance Dosage ganirelix 0,25 mg/0,5 ml ATC: H01CC01
Manufacturer: GP-PHARM S.A.